Seagen, Inc. logo

Seagen, Inc. Share Price (NASDAQ: SGEN)

▲

-228.74

(-100%)

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 12 Dec 2023

Check the interactive Seagen, Inc. Stock chart to analyse performance

Seagen, Inc. Key Stats

Check Seagen, Inc. key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$228.74
Open
$228.93
Market Capitalization
$43.2B
Today's Volume
$20.0M
Revenue TTM
$2.3B
EBITDA
$-677.4M
Earnings Per Share (EPS)
$-4.01
Dividend Yield
3.19%
Profit Margin
-32.61%
Quarterly Earnings Growth YOY
5.23%
Return On Equity TTM
-27.93%

Global Institutional Holdings in Seagen, Inc.

  • Name

    Holdings %

  • Baker Bros Advisors LP

    23.62%

  • Vanguard Group Inc

    7.06%

  • Pentwater Capital Management LP

    6.83%

  • BlackRock Inc

    6.39%

  • PRIMECAP Management Company

    3.32%

  • State Street Corporation

    1.78%

Analyst Recommendation on Seagen, Inc. Stock

Rating
Trend

Hold

    34%Buy

    65%Hold

    0%Sell

Based on 23 Wall street analysts offering stock ratings for Seagen, Inc.(by analysts ranked 0 to 5 stars)

About Seagen, Inc.

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. It offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of adult patients with advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. The company also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-TGT and SEA-CD70 for various cancer diseases. It has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.
Organization
Seagen, Inc.
Employees
3256
CEO
Mr. Todd E. Simpson
Industry
Health Technology

Important FAQs about investing in SGEN Stock from India :

What is Seagen, Inc. share price today?

Seagen, Inc. share price today is as on at the close of the market. Seagen, Inc. share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Seagen, Inc. share?

Seagen, Inc. share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Seagen, Inc. stock price today i.e. is closed at , lower by 100% versus the 52 week high.

How to invest in Seagen, Inc. Stock (SGEN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Seagen, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Seagen, Inc. Shares .

What is the minimum amount required to buy Seagen, Inc. Stock (SGEN) from India?

Indian investors can start investing in Seagen, Inc. (SGEN) shares with as little as ₹88.2013 or $1 (as of September 16, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.01 in Seagen, Inc. stock (as per the Rupee-Dollar exchange rate as on September 16, 2025). Learn more about fractional shares .

What are the returns that Seagen, Inc. has given to Indian investors in the last 5 years?

Seagen, Inc. stock has given 0.0% share price returns and 19.92% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?